Armata Pharmaceuticals, Inc. — Director's Dealing 2008

May 19, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2008-05-15

Reporting Person: LEVY NELSON L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-15	Common Stock	A	10000	$0.00	Acquired	20070	Direct

Footnotes

F1: These shares represent a grant of restricted stock units that vest 100% on May 15, 2009, the vesting of which shall accelerate upon a change of control, so long as the reporting person is providing services to the issuer on such date.